Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02042547
Other study ID # LAURENT PARI 2010
Secondary ID
Status Completed
Phase N/A
First received January 17, 2014
Last updated January 22, 2014
Start date September 2010

Study information

Verified date November 2010
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Observational

Clinical Trial Summary

Before la surgery:

Transthoracic cardiac echography will be done systematically, to measure among other things the size of the left atrium.

During surgery:

Surgery under extracorporeal circulation: tissue samples will be harvested from the right atrium (one before clamping of the aorta (T0= pre-ischemia sample), immediately before declamping of the aorta (T1= post-ischemia sample).

Surgery without extracorporeal circulation: tissue samples from the right atrium before CABG (T0) and a second sample after CABG (T1).

In parallel with the harvesting of cardiac tissue, blood samples will be taken at different times (H0, H3, H24) to correlate tissue data with systemic data. These will be taken by the anesthetists.

After the surgery:

Holter ECG will be set up for 7 days of continuous recording. Each patient will fill in an observation notebook. The biological samples will be analysed immediately and the biological data obtained will be recorded in the observation notebook.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria:

- Patients who have provided written informed consent

- Patients covered by the national health insurance scheme

- Heart surgery (CABG) with and without extracorporeal circulation

- Elective or deferred emergency surgery

- Consecutive patients aged less than 80 years

Exclusion Criteria:

- Patients less than 18, under guardianship

- Patients over 18, under guardianship

- Patients who do not understand the study data

- Patients undergoing emergency surgery who therefore cannot be given or understand the explanations for the study (patients in shock, intubated patients with mechanical ventilation)

- History of heart surgery

- History of AF

- Treatment with Cordarone.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Tissue samples from the right atrium

Blood samples


Locations

Country Name City State
France CHU de DIJON Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Onset or a de novo episode of atrial fibrillation during the 7 days following heart surgery 7 days post-surgery No
Secondary Markers of ischemia: circulating Troponin I before the surgery and at the end of the procedure Baseline and at the end of surgery (15 minutes after unclamping when extracorporeal circulation) No